107 related articles for article (PubMed ID: 23422370)
1. Donepezil treatment stabilizes functional connectivity during resting state and brain activity during memory encoding in Alzheimer's disease.
Solé-Padullés C; Bartrés-Faz D; Lladó A; Bosch B; Peña-Gómez C; Castellví M; Rami L; Bargalló N; Sánchez-Valle R; Molinuevo JL
J Clin Psychopharmacol; 2013 Apr; 33(2):199-205. PubMed ID: 23422370
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between episodic memory and resting-state brain functional connectivity network in patients with Alzheimer's disease and mild cognition impairment].
Wu QJ; Guo ZJ; Liu SE; Yu HQ; Chen J; Yang HM
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1795-800. PubMed ID: 24124712
[TBL] [Abstract][Full Text] [Related]
3. Effects of donepezil on brain morphometric and metabolic changes in patients with Alzheimer's disease: A DARTEL-based VBM and (1)H-MRS.
Moon CM; Kim BC; Jeong GW
Magn Reson Imaging; 2016 Sep; 34(7):1008-16. PubMed ID: 27131829
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
5. Functional connectivity increase in the default-mode network of patients with Alzheimer's disease after long-term treatment with Galantamine.
Blautzik J; Keeser D; Paolini M; Kirsch V; Berman A; Coates U; Reiser M; Teipel SJ; Meindl T
Eur Neuropsychopharmacol; 2016 Mar; 26(3):602-13. PubMed ID: 26796681
[TBL] [Abstract][Full Text] [Related]
6. Detection of PCC functional connectivity characteristics in resting-state fMRI in mild Alzheimer's disease.
Zhang HY; Wang SJ; Xing J; Liu B; Ma ZL; Yang M; Zhang ZJ; Teng GJ
Behav Brain Res; 2009 Jan; 197(1):103-8. PubMed ID: 18786570
[TBL] [Abstract][Full Text] [Related]
7. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
Sauer J; ffytche DH; Ballard C; Brown RG; Howard R
Brain; 2006 Jul; 129(Pt 7):1780-8. PubMed ID: 16670180
[TBL] [Abstract][Full Text] [Related]
8. Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.
Nahas Z; George MS; Horner MD; Markowitz JS; Li X; Lorberbaum JP; Owens SD; McGurk S; DeVane L; Risch SC
Neurocase; 2003 Jun; 9(3):274-82. PubMed ID: 12925933
[TBL] [Abstract][Full Text] [Related]
9. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
[TBL] [Abstract][Full Text] [Related]
10. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J
Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866
[TBL] [Abstract][Full Text] [Related]
11. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
Bokde AL; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel SJ; Möller HJ; Hampel H
Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329
[TBL] [Abstract][Full Text] [Related]
12. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
Jones RW; Kivipelto M; Feldman H; Sparks L; Doody R; Waters DD; Hey-Hadavi J; Breazna A; Schindler RJ; Ramos H;
Alzheimers Dement; 2008 Mar; 4(2):145-53. PubMed ID: 18631958
[TBL] [Abstract][Full Text] [Related]
13. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
Molinuevo JL; Berthier ML; Rami L
Arch Gerontol Geriatr; 2011; 52(1):18-22. PubMed ID: 19948364
[TBL] [Abstract][Full Text] [Related]
14. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI.
Wang L; Zang Y; He Y; Liang M; Zhang X; Tian L; Wu T; Jiang T; Li K
Neuroimage; 2006 Jun; 31(2):496-504. PubMed ID: 16473024
[TBL] [Abstract][Full Text] [Related]
15. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
[TBL] [Abstract][Full Text] [Related]
16. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
17. Donepezil treatment in Alzheimer's disease patients with and without cerebrovascular lesions: a preliminary report.
Na HR; Kim S; Choi SH; Yang DW; Bae HJ; Kim JE; Park MY; Shim YS; Kim BK; Kwon JC; Yoo BG; Kim BC; Lee JS
Geriatr Gerontol Int; 2011 Jan; 11(1):90-7. PubMed ID: 20825496
[TBL] [Abstract][Full Text] [Related]
18. Effect of donepezil on EEG spectral analysis in Alzheimer's disease.
Balkan S; Yaraş N; Mihçi E; Dora B; Ağar A; Yargiçoğlu P
Acta Neurol Belg; 2003 Sep; 103(3):164-9. PubMed ID: 14626697
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of donepezil on several cognitive functions in patients with Alzheimer's disease over 12 months].
López-Pousa S; Vilalta-Franch J; Garre-Olmo J; Turon-Estrada A; Lozano-Gallego M; Hernàndez-Ferràndiz M; Fajardo-Tibau C; Cruz-Reina MM
Neurologia; 2001 Oct; 16(8):342-7. PubMed ID: 11738011
[TBL] [Abstract][Full Text] [Related]
20. Donepezil effects on hippocampal and prefrontal functional connectivity in Alzheimer's disease: preliminary report.
Zaidel L; Allen G; Cullum CM; Briggs RW; Hynan LS; Weiner MF; McColl R; Gopinath KS; McDonald E; Rubin CD
J Alzheimers Dis; 2012; 31 Suppl 3(0 3):S221-6. PubMed ID: 22886013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
